Triple negative breast cancers (TNBC) is a breast carcinoma characterised by the absence of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) as defined by protein and/or gene amplification [1]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.